Bagnolet, France

Daniel Pinto

This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Institut Curie. Active years: 2006.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Daniel Pinto

Introduction

Daniel Pinto is an accomplished inventor based in Bagnolet, France. He has made significant contributions to the field of transgenesis, particularly through his work on the regulatory sequences of the mouse villin gene. His innovative approach has implications for the targeted expression of nucleic acid sequences in various epithelial cells.

Latest Patents

Daniel Pinto holds a patent for "Regulatory sequences of the mouse villin gene—use in transgenesis." This invention relates to regulatory sequences that efficiently drive transgenic expression in immature and differentiated epithelial cells of the intestine and urogenital tracts. The patent also encompasses recombinant constructs that utilize these regulatory sequences to control the targeted expression of specific nucleic acid sequences, known as heterologous sequences or transgenes, in cells or tissues derived from the intestinal mucosa. Furthermore, the invention aims to provide cells, tissues, or organisms, including animals, that express these nucleic acid sequences in a targeted manner.

Career Highlights

Throughout his career, Daniel Pinto has worked with prestigious institutions such as Institut Curie and the Centre National de la Recherche Scientifique. His work has been instrumental in advancing the understanding of gene regulation and transgenic technology.

Collaborations

Daniel Pinto has collaborated with notable colleagues, including Sylvie Robine and Frédéric Jaisser. These partnerships have contributed to the success of his research and innovations.

Conclusion

Daniel Pinto's contributions to the field of transgenesis highlight his innovative spirit and dedication to scientific advancement. His patent on the regulatory sequences of the mouse villin gene represents a significant step forward in targeted gene expression research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…